Results 351 to 360 of about 1,818,460 (375)
Some of the next articles are maybe not open access.
Human Pathology, 1996
In the past 10 years clinical trials have confirmed the value of breast conserving therapy for invasive breast cancer and many authorities now consider this the preferred and appropriate treatment (NCI Consensus Statement 1992a). However controversy still surrounds the treatment of ductal carcinoma in situ (DCIS).
openaire +5 more sources
In the past 10 years clinical trials have confirmed the value of breast conserving therapy for invasive breast cancer and many authorities now consider this the preferred and appropriate treatment (NCI Consensus Statement 1992a). However controversy still surrounds the treatment of ductal carcinoma in situ (DCIS).
openaire +5 more sources
2008
A. Epidemiology and Risk Factors. Ductal carcinoma in situ (DCIS) is a form of noninvasive breast cancer which usually affects women in their sixth decade of life. The disease is characterized by a proliferation of malignant ductal epithelial cells without microscopic invasion through the basement membrane.
Nicola L. P. Barnes, Nigel J. Bundred
openaire +3 more sources
A. Epidemiology and Risk Factors. Ductal carcinoma in situ (DCIS) is a form of noninvasive breast cancer which usually affects women in their sixth decade of life. The disease is characterized by a proliferation of malignant ductal epithelial cells without microscopic invasion through the basement membrane.
Nicola L. P. Barnes, Nigel J. Bundred
openaire +3 more sources
EMC - Ginecología-Obstetricia, 2021
Resumen El carcinoma ductal in situ (CDIS) se define como una proliferacion de celulas malignas en los conductos galactoforos, sin que atraviesen la membrana basal. El CDIS representa alrededor el 10-15% del conjunto de los canceres mamarios. Su tratamiento tiene por objetivo prevenir el desarrollo de un cancer infiltrante y, a la vez, evitar un ...
M Lodi +4 more
openaire +2 more sources
Resumen El carcinoma ductal in situ (CDIS) se define como una proliferacion de celulas malignas en los conductos galactoforos, sin que atraviesen la membrana basal. El CDIS representa alrededor el 10-15% del conjunto de los canceres mamarios. Su tratamiento tiene por objetivo prevenir el desarrollo de un cancer infiltrante y, a la vez, evitar un ...
M Lodi +4 more
openaire +2 more sources
Surgical Clinics of North America, 2013
Management of ductal carcinoma in situ (DCIS) has evolved from radical surgery to the option of a more minimally invasive approach. Data show that breast conservation surgery performed with administration of radiotherapy, like mastectomy, is feasible and safe.
openaire +3 more sources
Management of ductal carcinoma in situ (DCIS) has evolved from radical surgery to the option of a more minimally invasive approach. Data show that breast conservation surgery performed with administration of radiotherapy, like mastectomy, is feasible and safe.
openaire +3 more sources
Breast Disease, 2001
Ductal carcinoma in situ (DCIS) has become a predominant pathologic entity with the broad implementation of screening mammography. In the premammographic era, it represented less than 10% of all breast cancers. Although it now occupies as much as 30% of contemporary series, it remains a controversial subject of debate in terms of its management.
openaire +3 more sources
Ductal carcinoma in situ (DCIS) has become a predominant pathologic entity with the broad implementation of screening mammography. In the premammographic era, it represented less than 10% of all breast cancers. Although it now occupies as much as 30% of contemporary series, it remains a controversial subject of debate in terms of its management.
openaire +3 more sources
Ductal carcinoma of the parotid gland
The Journal of Laryngology & Otology, 1987A case of ductal carcinoma of the parotid gland is described. The medical literature contains only 13 previous reports on this kind of adenocarcinoma of the parotid gland. The tumour is characterized by its histologic resemblance to ductal carcinomas of the breast and prostate.
Hakon Ellermann Eriksen +2 more
openaire +3 more sources
2016
Ductal carcinoma in situ (DCIS) is defined as abnormally proliferating malignant cells confined to the breast milk ducts by the basement membrane. The prognosis of DCIS with microinvasion (DCISM) is intermediate between those of DCIS and invasive ductal cancer.
+7 more sources
Ductal carcinoma in situ (DCIS) is defined as abnormally proliferating malignant cells confined to the breast milk ducts by the basement membrane. The prognosis of DCIS with microinvasion (DCISM) is intermediate between those of DCIS and invasive ductal cancer.
+7 more sources
Hematology/Oncology Clinics of North America
In breast cancer (BC) pathogenesis models, normal cells acquire somatic mutations and there is a stepwise progression from high-risk lesions and ductal carcinoma in situ to invasive cancer. The precancer biology of mammary tissue warrants better characterization to understand how different BC subtypes emerge.
Brittany L, Bychkovsky +4 more
openaire +2 more sources
In breast cancer (BC) pathogenesis models, normal cells acquire somatic mutations and there is a stepwise progression from high-risk lesions and ductal carcinoma in situ to invasive cancer. The precancer biology of mammary tissue warrants better characterization to understand how different BC subtypes emerge.
Brittany L, Bychkovsky +4 more
openaire +2 more sources
Management of ductal carcinoma in situ
Seminars in Surgical Oncology, 1996The management of ductal carcinoma in situ (DCIS) is one of the most controversial topics in the treatment of breast cancer. With the introduction and utilization of screening mammography, clinically occult or microscopic DCIS has become the most frequent presentation of this disease.
openaire +3 more sources
2014
Ductal carcinoma in situ is a malignant proliferation of epithelial cells within the ducts with no invasion. DCIS (ductal carcinoma in situ) is a heterogenous group of lesions that have very different morphology, biology, and clinical behavior. It is considered to be a true precursor of invasive disease although not all DCIS progress to become invasive
openaire +4 more sources
Ductal carcinoma in situ is a malignant proliferation of epithelial cells within the ducts with no invasion. DCIS (ductal carcinoma in situ) is a heterogenous group of lesions that have very different morphology, biology, and clinical behavior. It is considered to be a true precursor of invasive disease although not all DCIS progress to become invasive
openaire +4 more sources